首页|期刊导航|药物分析学报（英文）|Novel insights into histone lysine methyltransferases in cancer therapy:From epigenetic regulation to selective drugs

Novel insights into histone lysine methyltransferases in cancer therapy:From epigenetic regulation to selective drugs

Qili Liao Jie Yang Shengfang Ge Peiwei Chai Jiayan Fan Renbing Jia

药物分析学报（英文）2023，Vol.13Issue(2)：127-141,15.

Novel insights into histone lysine methyltransferases in cancer therapy:From epigenetic regulation to selective drugs

Qili Liao ¹Jie Yang ¹Shengfang Ge ¹Peiwei Chai ¹Jiayan Fan ¹Renbing Jia¹

作者信息

1. Department of Ophthalmology,Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,200001,China||Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology,Shanghai,200001,China
折叠

摘要

关键词

Cancer/Epigenetics/Histone lysine methyltransferase/Epigenetic inhibitors/Combined therapeutic strategy/Clinical application

Key words

Cancer/Epigenetics/Histone lysine methyltransferase/Epigenetic inhibitors/Combined therapeutic strategy/Clinical application

引用本文复制引用

Qili Liao,Jie Yang,Shengfang Ge,Peiwei Chai,Jiayan Fan,Renbing Jia..Novel insights into histone lysine methyltransferases in cancer therapy:From epigenetic regulation to selective drugs[J].药物分析学报（英文）,2023,13(2):127-141,15.

基金项目

This work was supported by the Science and Technology Com-mission of Shanghai,China(Grant Nos.:20DZ2270800 and 19JC1410200),Innovative Research Team of High-Level Local Univer-sities in Shanghai,China(Grant No.:SHSMU-ZDCX20210900),and the National Natural Science Foundation of China(Grant No.:82073889). （Grant Nos.:20DZ2270800 and 19JC1410200）

药物分析学报（英文）

OACSCD

ISSN：2095-1779

访问量0

下载量0

段落导航